Cat.#: ACPP-1744
Despition | C1q Human Recombinant |
SIZE | 200 µg |
Purity | > 96.0%. |
Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
ACPP-1604 | Human GSK3B Protein (AC1604) | 2 µg | inquiry |
ACPP-1313 | Norepinephrine Transporter Blocking Peptide (AC1313) | 250 µg | inquiry |
ACPP-1088 | Synthetic Exosome Human CD24 Protein (AC1088) | 50 µg | inquiry |
ACPP-1174 | Synthetic Nanodisc Human CD97 Protein (AC1174) | 10 µg | inquiry |
ACPP-1608 | Human INHBC Protein (AC1608) | 2 µg | inquiry |
ACPP-1398 | Rat TIMP1 Protein (AC1398) | 2 µg | inquiry |
ACPP-1272 | Bestrophin Blocking Peptide (AC1272) | 250 µg | inquiry |
ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
ACPP-1510 | Human TIMP1 Protein, Sf9 (AC1510) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.